J clin oncol 2004 22:2540- 2545
WebBladder cancer is a common malignancy seen in older adults with coexisting medical illnesses. The management of patients with muscle invasive disease includes perioperative chemotherapy and radical... WebApr 14, 2024 · J Clin Oncol (2004) 22:1404–12. doi: 10.1200/JCO.2004.09.008. PubMed Abstract CrossRef Full Text Google Scholar. 9. Sanz MA, Coiteux V, Chevret S, Rayon C, Vilmer E, Sanz M, et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the …
J clin oncol 2004 22:2540- 2545
Did you know?
WebBackground. Gallbladder cancer (GBC) is rare but aggressive. The extent of surgical intervention for different GBC stages is non-uniform, ranging from cholecystectomy alone to extended resections including major hepatectomy, resection of adjacent organs and routine extrahepatic bile duct resection (EBDR). WebFluoropyrimidines, the mainstay agents for the treatment of colorectal cancer, alone or as a part of combination therapies, cause severe adverse reactions in about 10%–30% of patients. Dihydropyrimidine dehydrogenase (DPD), a key enzyme in the catabolism of 5-fluorouracil, has been intensively investigated in relation to fluoropyrimidine toxicity, and …
WebJul 1, 2004 · Dose-limiting toxicity (DLT) occurred in two of three patients treated at 33 mg/m (2). Intermediate dose levels of 27 and 30 mg/m (2) were then evaluated. The MTD … WebCombined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: Results of a phase I trial. Journal of Clinical Oncology, 22(13), 2540-2545. …
WebMay 31, 2011 · J Clin Oncol 11:2150–2157 PubMed CAS Google Scholar Kent E, Sandler H, Montie J (2004) Combinedmodality therapy with gemcitabine and radiotherapy as a … Web22. Zurück zum Zitat Nymann P, Hedelund L, Haedersdal M (2009) Intense pulsed light vs. long-pulsed dye laser treatment of telangiectasia after radiotherapy for breast cancer: a randomized split-lesion trial of two different treatments. ... J Clin Oncol 21(13):2545–2550 CrossRef PubMed. 26. Zurück zum Zitat Delanian S, Porcher R, Rudant J ...
WebJ Clin Oncol 22:2540-2545. © 2004 by American Society of Clinical Oncology INTRODUCTION Muscle-invasive bladder cancer is an in …
WebMost cited. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. A Phase III Randomized Trial of Lobectomy Versus Limited Resection for Small-sized Peripheral Non-small Cell Lung Cancer (JCOG0802/WJOG4607L) breakdown\u0027s 5lWebSep 21, 2016 · The Gynecologic Oncology Group (GOG) conducted a phase II trial of two platinum analogs and noted response rates of only 15% and 11% for carboplatin and iproplatin, respectively. 3 However, the GOG conducted a phase II study of mitolactol (dibromodulcitol), resulting in a 29% response rate. 4 Ifosfamide has also been identified … costco business center new yorkWebSep 22, 2009 · J Clin Oncol 2004, 22:2540–2545. Article CAS PubMed Google Scholar Oh KS, Soto DE, Smith DC, et al.: Combined-modality therapy with gemcitabine and radiation … costco business center ontario californiaWebMay 1, 2004 · Treatment with pemetrexed resulted in clinically equivalent efficacy outcomes, but with significantly fewer side effects compared with docetaxel in the second-line treatment of patients with advanced NSCLC and should be considered a standard treatment option for second-line NSCLC when available. costco business center opening hoursWebMay 15, 2024 · J Clin Oncol. 2004; 22 (5):777–84. [Google Scholar] 8. Herbst RS, Giaccone G, Schiller JH, et al. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: A phase III trial – INTACT 2. J Clin Oncol. 2004; 22 (5):785–94. costco business center ontario hoursWebWe are in building 2545, Suite 300. From I-285 South/West: Take I-285 from the airport to exit 38, Lawrenceville Hwy. Make a left onto Lawrenceville Hwy. Atlanta Cancer will be on … costco business center online orderWebApr 11, 2024 · BackgroundThere are a variety of treatment options for recurrent platinum-resistant ovarian cancer, and the optimal specific treatment still remains to be determined. Therefore, this Bayesian network meta-analysis was conducted to investigate the optimal treatment options for recurrent platinum-resistant ovarian cancer.MethodsPubmed, … breakdown\\u0027s 5o